Back

Global, regional and national burden of atrial fibrillation and flutter attributable to metabolic risks from 1990 to 2021: analysis of data from the global burden of disease study, 2021

1 April 2025 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation epidemiology and clinical outcome Prevalence and Incidence of Atrial Fibrillation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Lei Ding

Fuwai Hospital, CAMS and PUMC, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Major clinical outcomes in patients with symptomatic versus asymptomatic atrial fibrillation: a Bayesian and frequentist meta-analysis
Doctor P. Karakasis (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Regional disparities in the care and outcomes of atrial fibrillation patients in a universal health care system: a population-based cohort study
Doctor M. Shurrab (Sudbury, CA)
Abstract Slides Video
Presentation thumbnail
Elevated red cell distribution width (RDW) and adverse outcomes in patients with atrial fibrillation: new insights from a contemporary prospective study
Doctor M. Vitolo (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Impact of early rhythm control in young and middle-aged patients with depression or anxiety and new-onset atrial fibrillation
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on cardiac arrest: a nationwide cohort study
Miss D. Rajan (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation epidemiology and clinical outcome

The Event

Event poster

EHRA 2025

1 April 2025 10:30 CET
You may be interested in
thumbnail
Congress Presentation
The global burden of atrial fibrillation: implications for risk assessments and outcomes
thumbnail
Congress Session
Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle
thumbnail
Congress Presentation
Incidence, management and outcomes of patients with incident atrial fibrillation in the contemporary direct oral anti coagulants era. A national study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources